210 related articles for article (PubMed ID: 10575998)
21. Drugs for prevention and treatment of postmenopausal osteoporosis.
Med Lett Drugs Ther; 2000 Oct; 42(1090):97-100. PubMed ID: 11035622
[No Abstract] [Full Text] [Related]
22. Medications for postmenopausal osteoporosis prevention.
Harv Womens Health Watch; 2002 Dec; 10(4):6-7. PubMed ID: 12499127
[No Abstract] [Full Text] [Related]
23. Biochemical bone markers.
Chapman B
CAP Today; 1999 May; 13(5):70-2, 74-8, 78-9. PubMed ID: 10558046
[No Abstract] [Full Text] [Related]
24. [Osteoporosis].
Bartl R
Internist (Berl); 2002 Dec; 43(12):1529-30, 1533-43. PubMed ID: 12607392
[No Abstract] [Full Text] [Related]
25. [The role of raloxifene (Evista) in the treatment and prevention of postmenopausal osteoporosis].
Korsić M
Reumatizam; 2003; 50(2):55-7. PubMed ID: 15098379
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of postmenopausal osteoporosis with raloxifene].
Fedelesova V; Chylova K; Dzurik
Bratisl Lek Listy; 2000; 101(9):527-8. PubMed ID: 11187059
[TBL] [Abstract][Full Text] [Related]
27. Osteoporosis: evaluation and treatment.
Milott JL; Green SS; Schapira MM
Compr Ther; 2000; 26(3):183-9. PubMed ID: 10984823
[TBL] [Abstract][Full Text] [Related]
28. Alendronate in the treatment of osteoporosis.
Adami S
Aging (Milano); 1998 Apr; 10(2):159-60. PubMed ID: 9666215
[No Abstract] [Full Text] [Related]
29. [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?].
MMW Fortschr Med; 2004 May; 146(21):63. PubMed ID: 15373093
[No Abstract] [Full Text] [Related]
30. Raloxifene vs tamoxifen.
Goldstein SR
JAMA; 2007 Jan; 297(3):263-4; author reply 264. PubMed ID: 17227974
[No Abstract] [Full Text] [Related]
31. [Selective estrogen receptor modulators (SERMs)].
Chaki O
Nihon Rinsho; 2015 Oct; 73(10):1673-81. PubMed ID: 26529929
[TBL] [Abstract][Full Text] [Related]
32. Focus on primary care postmenopausal osteoporosis: an update.
Watts NB
Obstet Gynecol Surv; 2000 Dec; 55(12 Suppl 3):S49-55. PubMed ID: 11128912
[TBL] [Abstract][Full Text] [Related]
33. Osteoporosis: which current treatments reduce fracture risk?
Baran DT
Cleve Clin J Med; 2000 Oct; 67(10):701-3. PubMed ID: 11060956
[TBL] [Abstract][Full Text] [Related]
34. New help for old bones.
Hetzell CB
Nursing; 2005 May; 35(5):20-1. PubMed ID: 15879940
[No Abstract] [Full Text] [Related]
35. New developments in osteoporosis treatments.
Miller CA
Geriatr Nurs; 2000; 21(4):219, 223. PubMed ID: 10945890
[No Abstract] [Full Text] [Related]
36. [Diagnosis and treatment of postmenopausal osteoporosis].
Mizunuma H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():490-4. PubMed ID: 18161154
[No Abstract] [Full Text] [Related]
37. [Drug treatment of postmenopausal osteoporosis. What's New in 2006].
Roux C; Briot K; Dumarcet N; Bourgoin M; Chapurlat R; Christin-Maitre S; Cortet B; Costagliola D; Diebolt V; Lacoin F; Letombe B; Oberlin F; Orcel P; Ravaud P; Seret P; Thomas T; Vogel JY; Barna A; Nouyrigat E; Veyries ML; Yoldjian I
Presse Med; 2006 Oct; 35(10 Pt 2):1529-39. PubMed ID: 17028517
[No Abstract] [Full Text] [Related]
38. [Raloxifene hydrochloride].
Itabashi A
Nihon Rinsho; 2004 Feb; 62 Suppl 2():528-35. PubMed ID: 15035185
[No Abstract] [Full Text] [Related]
39. [Quality of life of patients suffering from osteoporosis treated with alendronate and salmon calcitonin].
Sapuła RA; Ostrowski T; Bojar I
Wiad Lek; 2002; 55 Suppl 1():444-7. PubMed ID: 15002282
[TBL] [Abstract][Full Text] [Related]
40. Biological basis of anti-resorptive therapies for osteoporosis.
Zaidi M
Aging (Milano); 1998 Apr; 10(2):157-8. PubMed ID: 9666212
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
